在GATA3和PPARG复制数增加的尿路癌中,HER2过度表达增加了复制数
Xiaolin Zhu1,2, Emily Chan1,3, Michelle L Turski1
1Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, United States.
The oncologist
|June 22, 2024
概括
在GATA3和PPARG中复制数的增加独立地预测HER2在尿路癌 (UC) 中的过度表达,而无需ERBB2放大. 这可以识别针对HER2向治疗的UC瘤.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- HER2 (ERBB2基因) 是尿路细胞癌 (UC) 的关键治疗点.
- 在ERBB2非放大UC中HER2过度表达的机制尚不清楚.
- 识别HER2过度表达的驱动因素对于有针对性的治疗选择至关重要.
研究的目的:
- 研究ERBB2非放大UC中的HER2过度表达的基因组基础.
- 在UC中识别HER2蛋白表达的潜在生物标志物.
- 探索转录因子GATA3,PPARG和HER2表达之间的关系.
主要方法:
- 使用免疫组织化学和下一代测序对172种UC瘤的分析.
- 使用斯隆·凯特林纪念馆/癌症基因组图谱 (MSK/TCGA) 数据集进行验证.
- 评估GATA3和PPARG副本数量的增加及其与ERBB2表达的关联.
主要成果:
- GATA3复制数获得独立预测的HER2蛋白和mRNA表达.
- PPARG复制数获得独立预测的HER2蛋白和mRNA表达.
- 这些协会独立于ERBB2放大.
结论:
- 在GATA3和PPARG中复制数的增加与UC中的HER2过度表达有关,即使没有ERBB2放大.
- GATA3和PPARG复制号状态可以识别适合HER2向治疗的UC瘤.
- 研究结果显示,UC中的光标记物和关键转录因子之间存在联系.
更多相关视频
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
10.1K
11:12Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.0K
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
